A clinical grade stem cell culture for regenerative medicine, StemFit Basic03, has been launched by Amsbio. Provided ready to use from an animal-origin free, the StemFit Basic03 medium provides stable and reproducible culture condition for induced pluripotent stem and embryonic…
Eikonix, a Cambridge, UK-based imaging and life science company, has been appointed exclusive distributor for the Stemmera range of stem cell research products. Stemmera is based in California, USA, with products including kits, culture medium, reagents, antibodies, buffers, solutions, and…
AN INDUSTRY consortium has been launched to optimise media and processes in order to manufacture stem cells and natural killer cells at volume. Based at the Centre for Commercialization of Regenerative Medicine (CCRM), a Canadian non-profit organisation, the consortium includes…
A NEW range of human feeder cells from Amsbio are qualified for induced Pluripotent Stem Cell (iPSC) reprogramming. These newborn human foreskin fibroblasts, available under the trade name NuFF-RQ, are validated to support iPSC colony generation, providing an optimised feeder…
THE TENTH annual Planet xMap symposium, to be held 10-11 October 2012 at the Grimaldi Forum in Monaco, has attracted over 500 delegate registrations reports Luminex. The symposium programme features scientific sessions, workshops, discussion groups, exhibitions, and networking events with…
LUMINEX has announced further details of its 10th annual Planet xMap congress, to be held on 10-11 October 2012 at the Grimaldi Forum in Monaco. Over 500 leading scientists are expected to gather at the event, sharing information and discoveries…
THE EMERGING field of single-cell genomics is enabling scientists to study previously unavailable genomic signatures from a single cell. Fluidigm believes its C1 system will prove to be the next big advance in the field. The C1 single-cell autoprep system…
REPROGRAMMING somatic cells into human induced pluripotent stem cell (hiPS) clusters brings with it the tantalising potential to create disease-specific and patient-specific human cell products. This in turn creates a need to produce a high number of hiPS cell lines,…
TAP Biosystems reports that I-Stem, the Institute for Stem cell Therapy and Exploration of Monogenic diseases, has selected two of its lab automation systems for installation at its headquarters at Evry, on the southern edge of Paris. The Tap CompacT…
AN EASY method of labelling cellular structures without transfection agents is now available from Amsbio. The company says its lentiviral particles allow the direct visualisation of organelles and other internal cell structures, without manipulation. Real-time visualisation conventionally requires the use…